Sentences with phrase «potential use of the vaccine»

One potential use of the vaccine candidate Stamatatos is developing would be to combine it with this or other vaccine candidates, adding to the effect of each.

Not exact matches

The World Health Organization (WHO) in Geneva, Switzerland, put the brakes on implementation of the world's first dengue vaccine today when it recommended it only be used in people who have previously been infected with the disease — a move that will shrink the potential market for the vaccine's producer, Sanofi Pasteur.

A spokesperson for the journal's publisher, PLOS, wrote in an email that a committee on «dual use research of concern» at the journal unanimously agreed that the benefits of publication, including «the potential improvements in vaccine development» outweighed the risks.

The results of the early - stage vaccine trial suggest that the preventive treatment should be developed further and that scientists are a step closer to being able to counter a potential H7N9 flu pandemic using a clinically tested vaccine, researchers argue April 30 in Science...

«Key benefits of large - scale use of universal over conventional flu vaccines: Mathematical model reveals potential effects of new vaccines that target multiple flu strains.»

Although the majority of childhood pneumococcal deaths occur in Africa, evidence of the potential impact of pneumococcal vaccines in routine use has largely been drawn from high - income countries.

Kang's primary research focuses on designing and developing effective vaccines against viral diseases such as influenza virus and RSV, but he partnered with a university and research institutes in South Korea that wanted international collaborative projects to study if ginseng can be used to improve health and protect against disease because of the potential benefit in fighting these viruses.

«We discovered that there was a lot of naturally occurring resistance, meaning we may need to greatly expand the set of viruses we use to evaluate potential vaccines,» says Ramy El - Diwany, a student at the Johns Hopkins University School of Medicine and first author of the study.

While the 3D injectable scaffold is being tested in mice as a potential cancer vaccine, any combination of different antigens and drugs could be loaded into the scaffold, meaning it could also be used to treat infectious diseases that may be resistant to conventional treatments.

In addition, more targeted use of the potential vaccines and drugs that scientists are currently working on intensively could be planned.

The researchers theorize that vaccinating camels could reduce the risk of MERS - CoV transmission to people and other camels; NIAID and others are supporting research to develop candidate vaccines for potential use in people and camels.

However, scientists believe for practical use, these potential vaccines would require multiple doses or the addition of adjuvants, which enhance the immune response.

Instead of a liquid containing whole killed or attenuated virus, this vaccine uses dry virus - like particles (VLPs) which simply coat the needles in the presence of a simple stabilizing agent, reducing the need for refrigeration — a potential boon for use in developing countries.

These findings highlight the need to (a) induce multiple neutralizing antibody lineages for a protective antibody - based vaccine and (b) the potential need to use combinations of purified mAb in therapeutic or prophylactic settings.

Late last week, FDA worked with the United States Attorney to ask a court to seize the components of a product that involved the use of vaccinia virus vaccine as part of a purported treatment for cancer that FDA believes created the potential for substantial risks to patients.

We will assess its potential effectiveness as a vaccine using state - of - the - art in vitro and translational techniques that were successful in our laboratory previously.

Part of this response was for development of vaccines for potential use in control, a potential facilitated by the rapid identification of the causative agent, a new coronavirus [8]--[9].

Massachusetts Institute of Technology (MIT) researchers have discovered a new way to model malaria using stem cells in a petri dish, which will allow them to test potential antimalarial drugs and vaccines.

For this purpose, the National Institute of Allergy and Infectious Diseases supported preparation of vaccines for evaluation for potential use in humans.

In this role, Ms. Roxland re-launched and chaired J&J's Ethics Committee, created an enterprise - wide consultation service for teams and individuals confronting complex research ethics issues, and provided guidance on issues such as post-trial access for former research participants, conducting clinical trials in war - torn regions, testing of a potential Ebola vaccine during a public health crisis, commercialization of stem cell therapies, subject recruitment and withdrawal, and expanded access / compassionate use.

The Delta VP30 technology has been approved by the National Institutes of Health for use under Biosafety Level 2 conditions and has been utilized safely for a decade to study the basic biology of the virus, identify potential antiviral compound candidates, and make the whole - virus vaccine.

Remember, recommendations vary depending on the age, breed, and health status of the cat, the potential of the cat to be exposed to the disease, the type of vaccine, whether the cat is used for breeding, and the geographical area where the cat lives or may visit.

Using parallel methods of protection as in humans, pet vaccines initiate defensive immune response, preparing the animal's body to fight a potential future infection.

Use of the recombinant FeLV vaccine offers the potential advantage of a decreased risk of sarcoma formation (Srivastav et al, 2012).

However, if the vaccine has the potential to sensitize cats to enhanced disease as suggested by the Cornell studies, it may not be appropriate to use it under conditions where exposure to high concentrations of infectious virus is likely.

«But we do know that using current and relevant respiratory vaccines may help to minimize the potential infectious causes of IAD, and help keep your horse performing to the best of its ability.»